Can old drugs learn new tricks? Achieving registration and public subsidy listing for off‐patent medicines with novel therapeutic applications
Internal Medicine Journal · 2023
DOI: 10.1111/imj.16159 ↗Kurz gefasst
Fachartikel in der Zeitschrift Internal Medicine Journal, 2023. Verfasst von Jonathan Brett und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacology and Toxicology, St Vincent's Hospital Sydney, Sydney, New South Wales, Australia. Hauptthemen laut MEDLINE: Nonprescription Drugs, Drug Costs. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHMRC, Centre of Research Excellence in Medications Intelligence, National Health and Medical Research Council.
Abstract (Originalsprache)
With the increasing costs of drug development, repurposing of low‐cost medicines for new indications has never been more important. However, there are multiple barriers to repurposing, particularly for off‐patent medicines, and limited incentives for the pharmaceutical industry to sponsor registration and public subsidy listing. Here, we explore these barriers and their consequences and provide examples of successful repurposing strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Pharmacology and Toxicology, St Vincent's Hospital Sydney, Sydney, New South Wales, Australia.
- Medicines Intelligence Centre for Research Excellence, University of New South Wales, Sydney, New South Wales, Australia.
- The George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia.
- Department of Philosophy, Macquarie University, Sydney, New South Wales, Australia.
- Department of Psychiatry, School of Clinical Sciences, Monash University, Melbourne, Victoria, Australia.
- Turner Institute for Brain and Mental Health, School of Psychological Sciences, Monash University, Melbourne, Victoria, Australia.
ORCID-Profile: Jonathan Brett, Dilara Bahceci, Ric O Day
Förderung
- NHMRC
- Centre of Research Excellence in Medications Intelligence
- National Health and Medical Research Council
Zitieren
APA
Brett, J., Bahceci, D., Lipworth, W., Liknaitzky, P., Day, R. O., & Rodgers, A. (2023). Can old drugs learn new tricks? Achieving registration and public subsidy listing for off‐patent medicines with novel therapeutic applications. Internal Medicine Journal. https://doi.org/10.1111/imj.16159
Vancouver
Brett J, Bahceci D, Lipworth W, Liknaitzky P, Day RO, Rodgers A. Can old drugs learn new tricks? Achieving registration and public subsidy listing for off‐patent medicines with novel therapeutic applications. Internal Medicine Journal. 2023. doi:10.1111/imj.16159
BibTeX
@article{Brett2023,
author = {Brett, Jonathan and Bahceci, Dilara and Lipworth, Wendy and Liknaitzky, Paul and Day, Ric O and Rodgers, Anthony},
title = {Can old drugs learn new tricks? Achieving registration and public subsidy listing for off‐patent medicines with novel therapeutic applications},
journal = {Internal Medicine Journal},
year = {2023},
doi = {10.1111/imj.16159}
}
EUVIMED